Cognitive Behavioral Therapy Normalizes Functional Connectivity for Social Threat in Psychosis. by Mason, L. et al.
684
Schizophrenia Bulletin vol. 42 no. 3 pp. 684–692, 2016 
doi:10.1093/schbul/sbv153
Advance Access publication October 27, 2015
 © The Author 2015. Published by Oxford University Press on behalf  of the Maryland Psychiatric Research Center. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits 
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Cognitive Behavioral Therapy Normalizes Functional Connectivity for Social Threat 
in Psychosis
Liam Mason*,1, Emmanuelle R. Peters1,2, Danai Dima3,4, Steven C. Williams5, and Veena Kumari1,2
1Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK; 2South 
London and Maudsley NHS Foundation Trust, NIHR Biomedical Research Centre for Mental Health, London, UK; 3MRC Social 
Genetic and Developmental Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK; 
4Psychosis Research Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY; 5Department of 
Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
*To whom correspondence should be addressed; Department of Psychology (P078), Institute of Psychiatry, Psychology and 
Neuroscience, King’s College London, Addiction Sciences Building, 4 Windsor Walk, Denmark Hill, London SE5 8BB, UK;  
tel: +44(0)20-7848-0233, e-mail: liam.mason@kcl.ac.uk
Psychosis is often characterized by paranoia and poor 
social functioning. Neurally, there is evidence of func-
tional dysconnectivity including abnormalities when pro-
cessing facial affect. We sought to establish whether these 
abnormalities are resolved by cognitive behavioral therapy 
for psychosis (CBTp). The study involved 38 outpatients 
with one or more persistent positive psychotic symptoms, 
and 20 healthy participants. All participants completed 
an implicit facial affect processing task during functional 
magnetic resonance imaging (fMRI). Subsequently, 
patients either continued to receive standard care only 
(SCO, n  =  16) or received CBTp on top of standard 
care (+CBTp, n = 22), with fMRI repeated 6–8 months 
later. To examine the mechanisms underlying CBTp-led 
changes in threat processing and appraisal, functional 
connectivity during the social threat (angry faces) con-
dition was assessed separately from left amygdala and 
right dorsolateral prefrontal cortex (DLPFC) seeds. At 
baseline, patients, compared with healthy participants, 
showed greater amygdala connectivity with the insula 
and visual areas, but less connectivity with somatosen-
sory areas. These differences normalized following CBTp 
and, compared with the SCO group, the +CBTp group 
showed greater increases in amygdala connectivity with 
DLPFC and inferior parietal lobule, with the latter cor-
relating with improvement in positive symptoms. From the 
DLPFC seed, the +CBTp (compared with SCO) group 
showed significantly greater increase in DLPFC connec-
tivity with other prefrontal regions including dorsal ante-
rior cingulate and ventromedial prefrontal cortex. These 
findings indicate that CBTp strengthens connectivity 
between higher-order cognitive systems and those involved 
in threat and salience, potentially facilitating reappraisal.
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Introduction
There has been a growing interest in understanding the 
neural effects of psychological interventions, to gain a 
better understanding of the maintaining mechanisms of 
disorders and to improve future therapies. There is now 
considerable evidence that interventions such as a cogni-
tive behavioral therapy produce lasting neural activation 
changes in a range of disorders.1 However, few to date 
have examined changes in the widespread connections 
between distributed systems. This is surprising, given 
that cognitive behavioral therapy targets dysfunctional 
appraisals of distributed cognitive, affective, and physical 
inputs.2 Remediation of functional connectivity is likely 
to be of particular importance in psychosis, which has 
long been conceptualized as a disorder of network dys-
connectivity.3,4 Yet, to date, none have examined changes 
in functional connectivity following psychological ther-
apy in psychosis.
Psychological models of psychosis emphasize a hyper-
vigilance for threat cues as well as a difficulty in disen-
gaging threat-related affective content from conscious 
awareness.5,6 Neurobiological accounts are in accordance 
with this view7 and there is convincing evidence of a bias 
to perceive facial expressions as threatening.8 This social 
threat network includes limbic (amygdala, putamen, thal-
amus), visual (fusiform gyrus), and prefrontal regions, in 
addition to the insula.9 In healthy participants, cogni-
tive reappraisal strategies have been shown to modulate 
activity in this network, through top-down connections 
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with frontal areas such as the dorsolateral prefrontal cor-
tex (DLPFC).10,11 However, in psychosis there is reduced 
amygdala connectivity with prefrontal regions when pro-
cessing threatening faces,12–14 as well as a reduced abil-
ity to regulate insula.15–17 At the symptom level, these 
abnormalities in social threat perception are likely to be 
involved in the generation and maintenance of persecu-
tory delusions and poor social functioning.18 Accordingly 
these are an important therapeutic target.
There is considerable evidence that psychological inter-
ventions target DLPFC and other prefrontal regions,1,19 
perhaps linking to a role in reappraisal of affective inputs 
mentioned previously.10,11 However, there are no studies to 
date that have examined changes in functional connectiv-
ity following psychological intervention in psychosis. In 
studies of social threat processing in anxiety disorders, 
functional connectivity of the amygdala has been impli-
cated both as a predictor of,20 and a responder to,21 CBT. 
Furthermore, in psychosis, connectivity changes follow-
ing treatment with antipsychotic medication frequently 
involve the DLPFC and parietal lobule, as well as other 
frontal and temporal areas.22–24 The inferior parietal lobule 
(IPL) is involved in empathy,25 self-awareness,16,26 and self-
other discrimination.27 Consistent with these functions, 
IPL has been linked to cognitive insight; the ability to 
reflect on one’s own beliefs and to entertain those of oth-
ers16,28 which is a predictor of favorable CBTp outcome.29
We have previously shown that cognitive behavioral 
therapy for psychosis (CBTp) brings about significant 
changes in the processing of social threat. Specifically, 
there was a reduction in the activation of arousal and 
salience regions including insula, thalamus, putamen, 
and visual areas, and these changes correlated with 
improvement in positive symptoms.30 The present study 
sought to elaborate on the mechanism underlying these 
functional activation changes by examining, in the same 
patients, concomitant changes in functional connectivity 
with higher-order cognitive systems. A  further aim was 
to establish whether CBTp-led changes result in normal-
ization of connectivity by additionally comparing con-
nectivity with healthy participants. We hypothesized that 
patients with psychosis would show greater recruitment 
of affective and salience regions with reduced regulation 
from higher cognitive areas. In line with this, we predicted 
greater amygdala connectivity with insula and reduced 
connectivity with DLPFC12–14 and the parietal lobule,22–24 
compared with healthy participants. We further predicted 
that these abnormalities would normalize following 
CBTp and that CBTp-led changes in connectivity would 
correlate with improvement in psychotic symptoms.
Methods
Participants and Design
Participants were 38 right-handed outpatients with a 
diagnosis of paranoid schizophrenia,31 and 20 healthy 
participants matched, on average, to patients for age, sex, 
handedness, and years of education (table  1). Patients 
were recruited from community services in the South 
London and Maudsley NHS Foundation Trust (SLaM). 
Creation of the study groups followed a cohort case-
controlled design in which one inclusion criteria was that 
all included patients were deemed as suitable for CBTp 
by consultant psychiatrists. Hence receipt vs nonreceipt 
of CBTp was independent of the research team and 
resulted from clinical resource limitations of the NHS 
Trust, rather than patient characteristics. Participants 
receiving standard care only (SCO group) were matched 
to participants receiving CBTp on top of standard care 
(+CBTp group) on the basis of having similar clinical 
and demographic characteristics. All patients had been 
on stable doses of antipsychotic medication for at least 
3 months at entry to the study (ie, at T1) and this was not 
changed during the study. Hence, only the +CBTp group 
received any additional intervention as part of the study. 
The study procedures were approved by the ethics com-
mittee of the joint research ethics committee of SLaM 
and Institute of Psychiatry, Psychology & Neuroscience 
in London (ref: 209/02). All participants provided written 
informed consent and were compensated for their time 
and travel.
Diagnosis was confirmed by means of  the Structured 
Clinical Interview for DSM-IV (SCID).31 Psychotic 
symptoms were assessed blindly at both time points 
using the Positive and Negative Syndrome Scale 
(PANSS).33 Mood symptoms were assessed using the 
Beck Depression Inventory-II.34 All participants under-
went functional magnetic resonance imaging (fMRI) 
at baseline (T1). Patients were scanned a second time 
6–8  months later (T2), following either CBTp in addi-
tion to standard care (+CBTp group, n  =  22) or stan-
dard care only (SCO group, n = 16). Healthy participants 
were recruited from the local community using existing 
research databases. Exclusion criteria included a history 
of  mental illness, drug and alcohol abuse or a regular 
medical prescription. The absence of  a clinical diagnosis 
in healthy participants was confirmed using the SCID 
nonpatient edition.35
Task
In the scanner, participants performed an implicit facial 
affect task in which they were presented with monochrome 
faces depicting fear, anger, happiness, or neutral expres-
sions.36 These 4 conditions were counterbalanced across 
16 blocks lasting 30 s (8 faces per block, with 3.75 s per 
face). Each block was followed by a 15 s block containing 
4 baseline trials in which an empty oval frame without 
the faces (but matched for luminance to the faces) was 
shown. On presentation of each face, participants had to 
indicate whether the face was male or female by pressing 
the left (female) or the right (male) button on a button 
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box. During the baseline blocks, they were required to 
press either the left or the right button when the empty 
oval frame appeared. All participants practiced the gen-
der discrimination task once on all identities on a laptop 
computer and an identical button box in advance of their 
scheduled fMRI scan.
Cognitive Behavioral Therapy for Psychosis and 
Standard Care Procedures
The +CBTp group received 6–8 months of manualized 
CBT for psychosis37 (see supplementary material).
Image Acquisition
Two hundred and forty T2*-weighted images were 
acquired using a 1.5 Tesla General Electric Signa system 
with the following parameters: echo time 40 ms, repetition 
time 3 s, flip angle 90°, field of view 240 mm, slice thickness 
7.0 mm, and interslice gap 0.7 mm. In the same session, 
a high-resolution structural scan (T1-weighted images 
in the axial plane with 1.5 mm contiguous sections) was 
acquired using a 3D inversion recovery prepared spoiled 
gradient recalled acquisition (echo time 5.1 ms, repetition 
time 18 ms, inversion time 450 ms, flip angle 20 degrees 
with one data average, and 256 × 256 × 128 voxel matrix).
Data Analysis
Sample Characteristics and Task Performance. Analysis 
of variance (ANOVA) was used to compare the patient 
and healthy participant groups on their age, predicted 
IQ,32 and years of education. For patient groups, duration 
of illness, age of onset, and number of episodes were also 
compared. For task performance, the percentage of cor-
rect trials for gender discrimination of facial expressions 
was compared across the 3 groups at baseline (T1) and 
across the 2 patient groups that completed the task a sec-
ond time (at T2) using ANOVA. For T1, the factors were 
group (healthy participants, SCO, +CBT) and condition 
(anger, happy, fear, neutral). This ANOVA was repeated 
for T2 including only the SCO and +CBT groups.
CBTp-led Changes in Symptoms and Task-Related 
Activations. The analysis of CBT-led changes in symp-
toms and task-related neural activation patterns have 
been reported in full elsewhere30 and as such are summa-
rized in the results section.
Table 1. Demographics, Task Performance, and Clinical Characteristics of Participants
+CBTp Group  
(n = 22, 18 Male)
SCO Group  
(n = 16, 14 Male)
Healthy 
Participants 
(n = 20, 15 Male)
Mean (SD) Mean (SD) Mean (SD)
Baseline Follow-up Baseline Follow-up Baseline
Age (years) 35.7 (7.82) 39.2 (9.37) 37.3 (12.5)
Education (years) 13.9 (3.26) 13.6 (1.71) 14.8 (3.0)
Predicted IQa 109.4 (9.68) 106.6 (9.73) 115 (8.0)
Age at illness onset 24.8 (8.38) 25.8 (8.49)
Duration of illness (years) 10.9 (7.70) 13.4 (10.2)
Medication Atypical antipsychotic 
(n = 20); combined atypical 
and typical (n = 2)
Atypical antipsychotic 
(n = 14); combined atypical 
and typical (n = 2)
Chlorpromazine equivalent (mg) 543 (479.3) 448.9 (338.8)
Gender 
Discrimination 
Accuracy (%)
Neutral 92.6 (10.8) 91.8 (13.1) 88.3 (10.8) 90.0 (14.6) 92.5 (18.3)
Fear 90.5 (14.4) 91.4 (16.5) 87.9 (20.9) 87.9 (18.5) 92.7 (15.8)
Anger 88.6 (15.2) 88.9 (14.2) 84.8 (16.1) 87.3 (19.1) 91.3 (19.4)
Happy 94.7 (8.48) 93.3 (9.94) 92.4 (7.82) 90.8 (12.3) 94.5 (18.7)
Detection (%) No face 93.4 (12.4) 91.5 (16.4) 93.8 (13.7) 92.5 (18.1) 93.8 (22.3)
PANSSb symptoms
Positive symptoms 18.1 (4.84) 14.9 (4.10) t(21) = 3.90* 18.6 (3.20) 18.1 (3.30)ns
Negative symptoms 17.7 (4.23) 15.6 (4.29) t(21) = 2.61* 19.1 (4.13) 20.3 (4.38)ns
General Psychopathology 33.5 (7.24) 28.6 (7.40) t(21) = 2.97* 35.4 (4.41) 35.4 (6.49)ns
Total symptoms 69.3 (13.3) 59.0 (14.7) t(21) = 3.72* 73.1 (9.28) 73.8 (11.8)ns
BDIc symptoms 16.2 (8.3)d 11.5 (9.9)*d t(19) = 2.19* 15.9 (10.4) 15.8 (12.1)ns
aNational Adult Reading Test.32
bPositive and Negative Syndrome Scale.33
cBeck Depression Inventory.34
dMissing data for 1 participant.
*Significant symptom reduction (P < 0.05) at follow-up relative to baseline.
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Functional Connectivity Analysis. We assessed func-
tional amygdala and DLPFC connectivity through the 
psycho-physiological interaction (PPI) approach38—see 
supplementary methods for more information.
CBTp-led Changes in Connectivity. The main analyses 
focused on direct social threat (angry faces) condition, as 
this yielded the highest neural activation and was respon-
sive to CBTp in previous work.30 The prosocial affect 
(happy faces) condition was also deemed to be of clinical 
importance given that patients with psychosis often mis-
read prosocial gestures,39 potentially in line with cognitive 
biases which are likely to be amenable to CBTp. These 
analyses are reported as supplementary material due to 
space constraints.
Separate voxel-wise PPI analyses yielded statistical 
parametric maps containing positive connectivity coeffi-
cients for healthy (T1 only) and patient groups (both T1 
and T2). After establishing that the 2 psychosis groups 
did not differ from each other at baseline, we established 
baseline abnormalities by comparing healthy participants 
to the patients (collapsed across groups) by using inde-
pendent-samples t-tests within a random-effects analysis. 
Next, we assessed longitudinal changes in the psychosis 
groups from T1 to T2 by entering the connectivity maps 
into a random-effects ANOVA with factors group (+CBT, 
SCO) and time (T1, T2). We focused on changes in the 
+CBT group and examined the group–time interaction to 
establish significant group differences over time. Finally, 
we assessed whether the baseline abnormalities (T1) were 
still present at T2 by comparing both clinical groups with 
the healthy group (reported as supplementary material). 
Based on previous reports of CBT effects in other disor-
ders,20,40,41 we expected that connectivity changes would 
be relatively subtle. We thus initially applied a threshold 
of uncorrected P < .001 (≥7 contiguous voxels) for all 
contrasts of interest. We then examined which findings 
survived more conservative family-wise error correction.
Finally, we examined whether the connectivity abnor-
malities observed at T1 were still present at T2, by com-
paring the +CBTp and SCO groups separately to the 
healthy group. The F-contrast “patients different from 
healthy participants” from T1 was used to functionally 
mask the contrasts at T2 (“+CBTp T2 different from 
healthy participants”; “SCO T2 different from healthy 
participants”). To reduce false negatives a more lenient 
threshold (uncorrected P < .05) was used to define the T1 
functional mask (with our standard threshold of uncor-
rected P < .001 kept for the T2 contrast).
Correlation with Symptoms and Assessing Normalization. 
After identifying areas of connectivity that responded 
to CBTp, we examined associations with symptom 
change on the PANSS in the +CBTp group. To do this, 
we first defined functional regions of interest (ROI) as 
2 mm spheres around the +CBTp group peaks of the 
connectivity changes (within-group and interactive 
effects). Next, we used MarsBar42 to extract the mean 
connectivity coefficients within these ROIs for both time 
points. We then explored associations between the CBTp-
led connectivity changes and symptom improvement. To 
reduce the risk of type 1 error due to multiple statistical 
tests and to test for effects at the multivariate level, we 
performed multivariate analysis of variance (MANOVA) 
instead of multiple univariate analyses.43 The CBTp-led 
connectivity changes were entered into a MANOVA as 
separate dependent variables and the changes on the pos-
itive and negative subscales of the PANSS were entered 
as additional regressors, separately for the 2 seeds. The 
direction of any significant effects was determined by 
partial correlation tests (uncorrected).
Results
Sample Characteristics and Baseline Task Performance
Sample characteristics for the 2 patient groups and the 
healthy group are reported in table 1. At baseline, there 
were no differences between groups in terms of age, 
sex, or years of education (P ≥ .39). There were differ-
ences in predicted IQ [F(2, 54)  =  4.69, P  =  .013], with 
the healthy participants showing higher scores than the 
SCO [t(54)  =  2.22, P  =  .03] and +CBT [t(54)  =  2.93, 
P = .005] groups but no difference between the 2 patient 
groups (P = .37). There were also no differences between 
the patient groups in terms of duration of illness, age of 
onset, number of episodes, or rates of drug use (P ≥ .19). 
Groups were also equivalent in terms of psychotic and 
depressive symptoms (P ≥ .32) and did not differ in their 
task performance for any condition at T1 (P ≥ .49) or at 
T2 (P ≥ .53).
CBTp-led Changes in Symptoms and Task-Related 
Activations
Only the +CBTp group showed a significant improve-
ment of symptoms at T2, as measured by PANSS and 
Beck Depression Inventory-II (table  1). Neurally, com-
pared with SCO, the +CBTp group showed significant 
reductions in activation (from T1 to T2) in left inferior 
frontal gyrus, left insula, bilateral putamen, and left 
occipital areas (table 3 in ref.30). In addition, these changes 
correlated with improvement in symptoms of psychosis 
(table 5 in ref.30).
Functional Connectivity Abnormalities in Patients at 
Baseline (T1)
Healthy participants showed positive amygdala connec-
tivity with several frontal areas, including right fronto-
polar cortex, right anterior cingulated, and left premotor 
cortex, as well as with left precuneus and thalamus (sup-
plementary table  1). Compared to healthy participants, 
patients (collapsed across groups) showed greater 
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amygdala connectivity with right lingual gyrus and left 
insula (straddling anterior and posterior segments), but 
less connectivity with left postcentral gyrus (table 2; see 
supplementary table  2 for network at T1 in psychosis 
participants).
From the DLPFC seed, healthy participants showed 
widespread connectivity, including right insula, bilateral 
inferior frontal gyrus, left premotor cortex, right visual 
cortex, right superior parietal lobule, as well as mid- 
and superior- temporal areas bilaterally (supplementary 
table  1). Similar connections were observed in the psy-
chosis participants, although there were no cingulate or 
precentral gyrus connections (supplementary table  2). 
However, differences between the healthy and psychosis 
participants did not reach significance at this time point.
Longitudinal Changes in Functional Connectivity (from 
T1 to T2)
There were no differences between the +CBT and SCO 
groups at baseline for either the amygdala or DLPFC 
seeded connectivity analyses at our voxel threshold 
(uncorrected P < .001).
Within the +CBTp group, there were T1 to T2 
increases in amygdala connectivity with left DLPFC 
and right IPL (figure 1; supplementary table 3) as well as 
bilateral premotor cortex and posterior cingulate gyrus. 
There were no reductions in connectivity in this group. 
To examine significant group differences in connectiv-
ity changes, we tested for group–time interaction effects. 
Compared with the SCO group, the +CBT group showed 
significantly greater increases in amygdala connectivity 
with right DLPFC, IPL, and posterior cingulate gyrus 
as well as left SPL, postcentral gyrus, and thalamus (fig-
ure 2, left pane). They also showed a greater reduction 
in connectivity with a cluster bordering left insula and 
inferior frontal gyrus.
From the DLPFC seed, the +CBTp group showed 
increased connectivity with left visual cortex (from T1 to 
T2; figure  3; supplementary table  4). The +CBT group 
showed significantly greater increases in DLPFC con-
nectivity with dorsal and subgenual portions of the left 
anterior cingulate cortex and with left posterior cingu-
late, extending into the IPL (figure 2, right pane).
Finally, none of the above findings survived family-
wise error correction.
Functional Connectivity Associations with 
Symptom Change
For the amygdala seed, the improvement in positive psy-
chotic symptom (PANSS-P) marginally covaried with the 
change connectivity with IPL [F(1, 19) = 3.28, P = .08; 
positive correlation: r(22) = .43, P = .05; figure 4] and SPL 
[F(1, 19) = 3.66, P = .07; positive correlation: r(22) = .4, 
P = .07]. There were no other univariate effects for either 
the amygdala (P ≥ .1) or DLPFC (P ≥ .11) models.
To better understand the relationship with symptoms, 
these effects were followed up with correlations with 
improvement on individual PANSS-P items. The increase 
in connectivity with IPL was specifically and positively 
correlated with improvement on the perceived persecu-
tion (PANSS-P6) item [Spearman’s ρ(22) = .66, P = .001] 
but no other items, either for IPL (P ≥ .26) or for SPL (P 
≥ .27) connections.
Functional Connectivity Abnormalities Revisited at T2
Further analyses examined whether the connectivity 
abnormalities observed at T1 were still present at T2, in 
the +CBTp and SCO groups separately. None of the 3 
baseline amygdala abnormalities remained in the +CBTp 
group when compared again to the healthy group at T2. 
In contrast, the SCO group continued to show dyscon-
nectivity with somatosensory cortex and, while dyscon-
nectivity with insula was no longer significant at our a 
priori statistical threshold, it remained at a less conser-
vative threshold (uncorrected P  =  .008). Furthermore, 
normalization of these abnormalities correlated with 
the CBTp-led changes in amygdala connectivity with 
DLPFC (see supplementary materials).
Discussion
This study found that CBTp resulted in reorganization of 
brain networks involved in processing social threat.
At baseline, psychosis patients showed amygdala 
hyperconnectivity with insula and visual occipital areas, 
compared with healthy participants. These findings are 
Table 2. Group Differences in Baseline (T1) Connectivity from Amygdala for Angry Faces Condition
Contrast
MNI Coordinates
Z Score Cluster Size Brodmann Area Regionx y z
AMYG
 Healthy > Patients 44 −16 28 3.1 7 3 Postcentral gyrus
 Patients > Healthy 32 −62 10 3.12 10 19/37 Lingual gyrus
−44 −10 22 3.06 1 (10*) 13 Insula
*Uncorrected P < .005.
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consistent with theoretical accounts of inappropriate acti-
vation of the salience network in psychosis, which may 
underlie hyper-vigilance to social threat and susceptibility 
to paranoia.17 The psychosis groups additionally showed 
reduced connectivity between amygdala and somatosen-
sory areas. This finding is consistent with previous reports 
in psychosis of reduced activation in somatosensory areas 
when processing facial affect, which is associated with 
social anhedonia.44 Although not predicted, this is in line 
with previous reports of reduced activation in somato-
sensory areas when processing facial affect and can be 
explained by the role of the somatosensory cortex in sup-
porting recognition of facial affect by providing a visuo-
somatic reference template.45 Hence, reduced coupling 
Fig. 2. Cognitive behavioral therapy for psychosis (CBTp) increases threat-related dorsolateral prefrontal cortical connectivity. There 
were post-therapy increases in connectivity with visual, prefrontal, and cingulate cortices in the +CBTp but not SCO group. Visualized 
with voxel threshold of P < .005 (uncorrected) around centre x = −49, y = −73, z = 8.
Fig. 1. Cognitive behavioral therapy for psychosis (CBTp) increases threat-related amygdala connectivity. At baseline (T1), the prefrontal 
and visual cortical connectivity evident in healthy participants (far left) were not evident in the psychosis participants. There were post-
therapy increases in connectivity in these connections, as well as the inferior parietal lobule, in the +CBTp but not SCO group. Visualized 
with voxel threshold of P < .005 (uncorrected) around centre x = −43, y = −76, z = 33.
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between amygdala and somatosensory cortex may indicate 
that when engaging in facial affect discrimination, people 
with psychosis do not optimally integrate affective and 
perceptual aspects, a finding which may explain misper-
ception of affect.18 Importantly, there was evidence that 
these baseline differences normalized following CBTp, 
whereas the group receiving SCO continued to show amyg-
dala dysconnectivity with somatosensory areas, compared 
with the healthy group. This CBTp-specific normalization 
tallies with reports that social skills training interventions 
result in increased somatosensory activation during facial 
affect recognition.46,47
In addition to normalization, there was additionally a 
widespread proliferation in connectivity post CBTp, as 
evidenced by changes in the number and strength of con-
nections from amygdala and DLPFC (from T1 to T2). 
This diverse proliferation of functional connections is 
evidence that CBTp promotes integration of multiple 
and distributed neural systems, which may be particularly 
relevant for psychosis as a dysconnectivity syndrome.3
Many of these connections occurred within the threat 
network, including amygdala, inferior frontal gyrus, thal-
amus, and visual areas, which had, in previous analyses, 
shown reduced activation following CBTp.30 Together, 
these analyses better explicate a therapeutic mechanism 
in which aberrant threat network activation is reduced 
following CBTp, perhaps especially through improved 
top-down regulation from prefrontal cortical regions. 
There was also evidence of greater connectivity within 
prefrontal cortical networks, as evidenced by greater 
DLPFC connectivity with dorsal anterior cingulate cor-
tex, involved in cognitive control,48 as well as ventrome-
dial prefrontal cortex, which may act as a gateway for 
regulatory DLPFC projections to amygdala.49 Hence, 
CBTp may reduce threatening appraisals by integrating 
affective and salience signals with higher cognitive pro-
cesses, such as reappraisal.11 Although not tested here, 
this explanation is in line with the aims of CBTp to shape 
cognitive appraisals of anomalous experiences and to 
regulate affective disturbances.6,37
Although no other studies have examined changes in 
connectivity following psychological therapy for psy-
chosis, there is initial evidence of  increased DLPFC 
regulation of  amygdala during facial affective process-
ing in social anxiety disorder.21 Further work will be 
Fig. 3. Cognitive behavioral therapy for psychosis (CBTp) increases functional connectivity for processing social threat. Compared 
with the standard care control group, the +CBTp group showed significantly greater increases in amygdala connectivity with a range 
of regions, including dorsolateral prefrontal cortex (DLPFC) and the inferior parietal lobule (left). Similarly the +CBTp group showed 
greater increases in DLPFC connectivity with other executive control regions, including dorsal (and ventral, not shown) portions of the 
anterior cingulate (right). Group-by-time interaction visualized with voxel threshold of P < .005 (uncorrected) around crosshair centres: 
amygdala (x = −43, y = 11, z = 41] and DLPFC (x = −10, y = 34, z = 4).
Fig. 4. Increase in amygdala connectivity with inferior parietal 
lobule following cognitive behavioral therapy for psychosis 
correlates with improvement in positive symptoms of psychosis 
(PANSS-P). Connectivity scale is in beta values.
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needed to examine the possibility that this represents 
a transdiagnostic therapeutic mechanism for social 
threat.
Also of clinical importance were the CBTp-specific 
increases in amygdala connectivity with IPL, which cor-
related with improvement in persecutory beliefs (mea-
sured by the positive symptoms scale of the PANSS). 
This may be attributable to the role of the IPL in self-
other discrimination generally27 as well as clinical and 
cognitive insight in psychosis.16,28 There is evidence of 
increased (superior) parietal lobule connectivity follow-
ing pharmacotherapy with antipsychotics,22 highlighting 
a common outcome irrespective of treatment modality. 
Further work will be needed to probe the potential over-
lap in neural mechanisms.
A limitation of the current study design is that the 
groups were not randomized and so we cannot rule out 
effects of selection bias for take-up of CBTp. In addi-
tion, healthy participants were only tested once and so 
our analyses to determine normalization did not take 
into account potential practice effects that could have 
occurred in the healthy participants had they been tested 
a second time. The present results did not survive family-
wise error correction, increasing the possibility of type 
1 errors. It should be noted however that the statistical 
threshold we applied is at least equal to, if  not more con-
servative than, all extant reports of connectivity changes 
following CBT in other disorders.20,40,41 Collectively, the 
research indicates that the changes are relatively subtle or 
not well captured by existing data capture and/or analysis 
methods.
In summary, this study provides evidence that CBTp 
leads to reorganization of amygdala and prefrontal cor-
tex connections mediating social threat processing. These 
changes included, but go beyond, normalization of the 
pathophysiology detected at baseline and include addi-
tional, compensatory changes. Only a single (prefronto-
parietal cortical) connection correlated with improvement 
in psychotic symptoms, highlighting that additional, 
more sophisticated clinical psychometrics are needed to 
better capture the psychoneurobiological changes follow-
ing CBTp.
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Supplementary material is available at http://schizophre-
niabulletin.oxfordjournals.org.
Funding
The Wellcome Trust (067427/z/02/z SRF to V.K.); 
Biomedical Research Centre for Mental Health at the 
Institute of Psychiatry, Psychology & Neuroscience 
(King’s College London) and South London and 
Maudsley NHS Foundation Trust, UK (partial support 
to V.K.).
Acknowledgments
We express our appreciation to the Psychological 
Interventions Clinic for outpatients with Psychosis 
(PICuP; South London and Maudsley NHS Foundation 
Trust), for providing CBTp for this study. All authors 
report that they have no biomedical financial interests or 
potential conflicts of interest.
References
 1. Barsaglini A, Sartori G, Benetti S, Pettersson-Yeo W, Mechelli 
A. The effects of psychotherapy on brain function: a system-
atic and critical review. Prog Neurobiol. 2014;114:1–14.
 2. Beck AT. Cognitive Therapy and the Emotional Disorders. 
New York: International University Press; 1976.
 3. Friston KJ, Frith CD. Schizophrenia: a disconnection syn-
drome. Clin Neurosci. 1995;3:89–97.
 4. Woodward ND, Waldie B, Rogers B, Tibbo P, Seres P, Purdon 
SE. Abnormal prefrontal cortical activity and connectivity 
during response selection in first episode psychosis, chronic 
schizophrenia, and unaffected siblings of individuals with 
schizophrenia. Schizophr Res. 2009;109:182–190.
 5. Green MJ, Phillips ML. Social threat perception and the evo-
lution of paranoia. Neurosci Biobehav Rev. 2004;28:333–342.
 6. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington 
PE. A cognitive model of the positive symptoms of psychosis. 
Psychol Med. 2001;31:189–195.
 7. Corlett PR, Taylor JR, Wang XJ, Fletcher PC, Krystal 
JH. Toward a neurobiology of delusions. Prog Neurobiol. 
2010;92:345–369.
 8. Taylor SF, Kang J, Brege IS, Tso IF, Hosanagar A, Johnson 
TD. Meta-analysis of functional neuroimaging studies of 
emotion perception and experience in schizophrenia. Biol 
Psychiatry. 2012;71:136–145.
 9. Fusar-Poli P, Placentino A, Carletti F, et al. Functional atlas 
of emotional faces processing: a voxel-based meta-analysis 
of 105 functional magnetic resonance imaging studies. J 
Psychiatry Neurosci. 2009;34:418–432.
 10. Wager TD, Davidson ML, Hughes BL, Lindquist MA, 
Ochsner KN. Prefrontal-subcortical pathways mediating suc-
cessful emotion regulation. Neuron. 2008;59:1037–1050.
 11. Ochsner KN, Bunge SA, Gross JJ, Gabrieli JD. Rethinking 
feelings: an FMRI study of the cognitive regulation of emo-
tion. J Cogn Neurosci. 2002;14:1215–1229.
 12. Das P, Kemp AH, Flynn G, et al. Functional disconnections 
in the direct and indirect amygdala pathways for fear process-
ing in schizophrenia. Schizophr Res. 2007;90:284–294.
 13. Fakra E, Salgado-Pineda P, Delaveau P, Hariri AR, 
Blin O. Neural bases of  different cognitive strategies for 
facial affect processing in schizophrenia. Schizophr Res. 
2008;100:191–205.
 14. Leitman DI, Loughead J, Wolf DH, et al. Abnormal superior 
temporal connectivity during fear perception in schizophre-
nia. Schizophr Bull. 2008;34:673–678.
 15. Ruiz S, Lee S, Soekadar SR, et  al. Acquired self-control 
of insula cortex modulates emotion recognition and brain 
network connectivity in schizophrenia. Hum Brain Mapp. 
2013;34:200–212.
 16. van der Meer L, de Vos AE, Stiekema AP, et al. Insight in 
schizophrenia: involvement of self-reflection networks? 
Schizophr Bull. 2013;39:1288–1295.
692
L. Mason et al
 17. Palaniyappan L, Liddle PF. Does the salience network play a 
cardinal role in psychosis? An emerging hypothesis of insular 
dysfunction. J Psychiatry Neurosci. 2012;37:17–27.
 18. Couture SM, Penn DL, Roberts DL. The functional signifi-
cance of social cognition in schizophrenia: a review. Schizophr 
Bull. 2006;32(suppl 1):S44–S63.
 19. Kumari V. Do psychotherapies produce neurobiological 
effects? Acta Neuropsychiatrica. 2006;18:61–70.
 20. Lueken U, Straube B, Konrad C, et  al. Neural substrates 
of treatment response to cognitive-behavioral therapy 
in panic disorder with agoraphobia. Am J Psychiatry. 
2013;170:1345–1355.
 21. Månsson KN, Carlbring P, Frick A, et al. Altered neural cor-
relates of affective processing after internet-delivered cogni-
tive behavior therapy for social anxiety disorder. Psychiatry 
Res. 2013;214:229–237.
 22. Schmidt A, Smieskova R, Aston J, et  al. Brain connectiv-
ity abnormalities predating the onset of psychosis: cor-
relation with the effect of medication. JAMA Psychiatry. 
2013;70:903–912.
 23. Lui S, Li T, Deng W, et  al. Short-term effects of  antip-
sychotic treatment on cerebral function in drug-naive 
first-episode schizophrenia revealed by “resting state” func-
tional magnetic resonance imaging. Arch Gen Psychiatry. 
2010;67:783–792.
 24. Sarpal DK, Robinson DG, Lencz T, et  al. Antipsychotic 
treatment and functional connectivity of the striatum in first-
episode schizophrenia. JAMA Psychiatry. 2015;72:5–13.
 25. Iacoboni M. Neural mechanisms of imitation. Curr Opin 
Neurobiol. 2005;15:632–637.
 26. Raij TT, Riekki TJ, Hari R. Association of poor insight 
in schizophrenia with structure and function of cortical 
midline structures and frontopolar cortex. Schizophr Res. 
2012;139:27–32.
 27. Uddin LQ, Molnar-Szakacs I, Zaidel E, Iacoboni M. rTMS 
to the right inferior parietal lobule disrupts self-other dis-
crimination. Soc Cogn Affect Neurosci. 2006;1:65–71.
 28. Gerretsen P, Menon M, Mamo DC, et al. Impaired insight 
into illness and cognitive insight in schizophrenia spectrum 
disorders: resting state functional connectivity. Schizophr 
Res. 2014;160:43–50.
 29. Perivoliotis D, Grant PM, Peters ER, Ison R, Kuipers E, 
Beck AT. Cognitive insight predicts favorable outcome 
in cognitive behavioral therapy for psychosis. Psychosis 
2010;2:23–33.
 30. Kumari V, Fannon D, Peters ER, et al. Neural changes fol-
lowing cognitive behaviour therapy for psychosis: a longitu-
dinal study. Brain. 2011;134:2396–2407.
 31. First M, Spitzer R, Williams J, Gibbon M. Structured Clinical 
Interview for DSM-IV (SCID) Washington. DC: American 
Psychiatric Association; 1995.
 32. Nelson HE, Willison J. National Adult Reading Test (NART). 
Windsor, UK: Nfer-Nelson; 1991.
 33. Kay SR, Fiszbein A, Opler LA. The positive and negative 
syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 
1987;13:261–276.
 34. Beck AT, Steer RA, Brown GK. Beck Depression Inventory-II. 
San Antonio, TX: Psychological Corporation; 1996.
 35. First M, Spitzer R, Williams J, Gibbon M. Structured Clinical 
Interview for DSM-IV-Non-Patient Edition (SCID-NP, 
Version 1.0). Washington, DC: American Psychiatric 
Association; 1995.
 36. Ekman P, Friesen WV, Press CP. Pictures of Facial Affect. 
Palo Alto, CA: Consulting Psychologists Press; 1975.
 37. Fowler D, Garety P, Kuipers E. Cognitive behaviour therapy 
for psychosis: theory and practice, Vol 68. Chichester, UK: 
Wiley; 1995.
 38. Friston KJ, Buechel C, Fink GR, Morris J, Rolls E, Dolan 
RJ. Psychophysiological and modulatory interactions in neu-
roimaging. Neuroimage. 1997;6:218–229.
 39. Hooker C, Park S. Emotion processing and its relationship to 
social functioning in schizophrenia patients. Psychiatry Res. 
2002;112:41–50.
 40. Goldin PR, Ziv M, Jazaieri H, Hahn K, Heimberg R, Gross 
JJ. Impact of cognitive behavioral therapy for social anxi-
ety disorder on the neural dynamics of cognitive reappraisal 
of negative self-beliefs: randomized clinical trial. JAMA 
Psychiatry. 2013;70:1048–1056.
 41. Kircher T, Arolt V, Jansen A, et al. Effect of cognitive-behav-
ioral therapy on neural correlates of fear conditioning in 
panic disorder. Biol Psychiatry. 2013;73:93–101.
 42. Brett M, Anton J-L, Valabregue R, Poline J-B. Region of 
interest analysis using the MarsBar toolbox for SPM 99. 
Neuroimage. 2002;16:S497.
 43. Huberty CJ, Morris JD. Multivariate analysis versus multiple 
univariate analyses. Psychol Bull. 1989;105:302.
 44. Germine LT, Garrido L, Bruce L, Hooker C. Social anhedo-
nia is associated with neural abnormalities during face emo-
tion processing. Neuroimage. 2011;58:935–945.
 45. Pourtois G, Sander D, Andres M, et al. Dissociable roles 
of the human somatosensory and superior temporal cor-
tices for processing social face signals. Eur J Neurosci. 
2004;20:3507–3515.
 46. Habel U, Koch K, Kellermann T, et  al. Training of affect 
recognition in schizophrenia: Neurobiological correlates. Soc 
Neurosci. 2010;5:92–104.
 47. Hooker CI, Bruce L, Fisher M, Verosky SC, Miyakawa A, 
Vinogradov S. Neural activity during emotion recognition 
after combined cognitive plus social cognitive training in 
schizophrenia. Schizophr Res. 2012;139:53–59.
 48. Duncan J, Owen AM. Common regions of the human frontal 
lobe recruited by diverse cognitive demands. Trends Neurosci. 
2000;23:475–483.
 49. Etkin A, Egner T, Kalisch R. Emotional processing in ante-
rior cingulate and medial prefrontal cortex. Trends Cogn Sci. 
2011;15:85–93.
